<?xml version="1.0" encoding="UTF-8"?>
<Label drug="cipro0" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  In Phase 3 clinical trials, a total of 564 patients were treated with CIPRO  (r)  HC OTIC. Adverse events with at least remote relationship to treatment included headache (1.2%) and pruritus (0.4%). The following treatment-related adverse events were each reported in a single patient: migraine, hypesthesia, paresthesia, fungal dermatitis, cough, rash, urticaria, and alopecia.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
